Insulin deficiency, such as in the case of Type 1 diabetes, leads to significant metabolic challenges within the body. When the body is unable to produce adequate amounts of insulin, the balance of glucose and lipid metabolism is disrupted. This lack of insulin results in several key issues.
Firstly, lipolysis in adipose tissues accelerates, flooding the bloodstream with free fatty acids. These free fatty acids are then taken up by the liver, where they are reassembled into triacylglycerols and re-released into the blood, increasing their levels.
Moreover, the reduced presence of insulin means diminished activity of lipoprotein lipase. This enzyme's reduced activity leads to decreased breakdown of circulating triacylglycerols, compounding their elevated levels in the bloodstream.
- Increased lipolysis leads to more free fatty acids and subsequent triacylglycerol production in the liver.
- Reduced LPL activity hinders the clearance of these triacylglycerols from the blood.
These processes explain why individuals with insulin-dependent diabetes often have high blood levels of triacylglycerols.